Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AXGN | Common Stock | Options Exercise | $0 | +11.9K | +41.17% | $0.00 | 40.8K | Sep 1, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AXGN | Restricted Stock Units | Options Exercise | $0 | -11.9K | -100% | $0.00 | 0 | Sep 1, 2024 | Common Stock | 11.9K | Direct | F2, F3 |
Id | Content |
---|---|
F1 | This reflects the number of restricted stock units that vested on September 1, 2024. |
F2 | Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. |
F3 | Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date. |